JMIR Publications

ABSTRACT

Background:

The integration of artificial intelligence (AI) into clinical medicine presents a paradox: diagnostic models routinely demonstrate benchmark superiority over human experts, yet bedside adoption remains low and clinician trust is fragile. Conventional approaches address this gap through forecasting—projecting model performance metrics along optimistic trend lines—but forecasting cannot account for the non-linear socio-technical transitions that separate technical capability from institutional trust.

Objective:

This Viewpoint applies Backcasting, a normative futures methodology with a four-decade evidence base in energy policy and public governance, to the specific problem of AI adoption in clinical medicine.

Methods:

Starting from a defined 2040 Vision State—a health care ecosystem in which clinician trust in AI diagnostics has reached a stable threshold—we identify three temporal Pivot Points that must be engineered, not waited for: (1) the 2030 standardization of Dual-Process AI Architectures, in which Large Language Models (LLMs) are verified in real time by locally deployed Small Language Models (SLMs); (2) the 2035 emergence of agentic orchestration workflows governed by an institutionalized Chief AI Officer (CAIO) role; and (3) the 2040 integration of Futures Literacy into medical education.

Results:

Key Insights: 1). The primary barrier is regulatory and institutional, not technological; 2). Proactive safeguards address automation bias, algorithmic equity, and fragmented liability; 3). Patient trust requires parallel attention through explainable outputs and CAIO-led education.

Conclusions:

The roadmap transforms the question from "when will AI be ready for medicine?" to "what must we build to make medicine ready for AI?"—offering structural commitments for clinicians, health systems, and policymakers to begin building today.